ACE and heart failure: These observations form the rationale for neurohormonal antagonists for treatment and prevention of heart failure with beta-adrenergic receptor blockers, angiotensin-converting enzyme (ACE) inhibitors, angiotensin receptor blockers (ARBs), and mineralocorticoid receptor antagonists (MRAs).